CLAY WATSON: Open Payments
NPI 1912661307 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 19 payments from 9 companies in 2025. Trend: 2023 $225 · 2024 $168 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $114 |
| ABBVIE INC. | 5 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $82 |
| Neurocrine BioSciences, Inc. | 4 | $82 |
| Lundbeck LLC | 1 | $33 |
| Alkermes, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: SPRAVATO, VRAYLAR, CAPLYTA, INGREZZA, REXULTI, ARISTADA, HETLIOZ, TRINTELLIX.
Industry payments across SC — which companies pay providers there.
